OGA heterozygosity suppresses intestinal tumorigenesis in Apc min/+ mice

Oncogenesis

Volumn 3, Issue , 2014, Pages

  Yang, Y R ^a   Jang, H J ^a,b   Yoon, S ^a   Lee, Y H ^a   Nam, D ^a   Kim, I S ^a   Lee, H ^c   Kim, H ^d   Choi, J H ^a   Kang, B H ^a   Ryu, S H ^b   Suh, P G ^a  

^a Ulsan National Institute of Science and Technology   (South Korea)

^b Pohang University of Science and Technology (POSTECH)   (South Korea)

^c National Cancer Center   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; BETA CATENIN; ENZYME; O GLCNAC TRANSFERASE; O GLCNACASE; TRANSFERASE; UNCLASSIFIED DRUG; WNT PROTEIN; O LINKED N ACETYLGLUCOSAMINE TRANSFERASE;

ACYLATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER SPECIFIC SURVIVAL; CANCER SURVIVAL; COLON CARCINOGENESIS; COLON POLYPOSIS; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME METABOLISM; GENE INACTIVATION; GENE MUTATION; GENE TARGETING; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL RATE; TUMOR GROWTH; UPREGULATION; WNT SIGNALING PATHWAY; CARCINOGENESIS; COLORECTAL ADENOMA; GENE EXPRESSION; INTESTINE CANCER; SIGNAL TRANSDUCTION;

ANIMALIA; MUS;

EID: 84904810180     PISSN: None     EISSN: 21579024     Source Type: Journal    
DOI: 10.1038/oncsis.2014.24     Document Type: Article

References (25)

1. Hart GW, Housley MP, Slawson C. Cycling of O-linked beta-N- acetylglucosamine on nucleocytoplasmic proteins. Nature 2007; 446: 1017-1022. (Pubitemid 46676063)
2. Mi WY, Gu YC, Han CF, Liu HY, Fan QO, Zhang XL et al. O-GlcNAcylation is a novel regulator of lung and colon cancer malignancy. Biochim Biophys Acta 2011; 1812: 514-519.
3. Slawson C, Pidala J, Potter R. Increased N-acetyl-beta-glucosaminidase activity in primary breast carcinomas corresponds to a decrease in N-acetylglucosamine containing proteins. Biochim Biophys Acta 2001; 1537: 147-157. (Pubitemid 32885616)
4. Gu Y, Mi W, Ge Y, Liu H, Fan Q, Han C et al. GlcNAcylation plays an essential role in breast cancer metastasis. Cancer Res 2010; 70: 6344-6351.
5. Zhu Q, Zhou L, Yang Z, Lai M, Xie H, Wu L et al. O-GlcNAcylation plays a role in tumor recurrence of hepatocellular carcinoma following liver transplantation. Med Oncol 2012; 29: 985-993.
6. Lynch TP, Ferrer CM, Jackson SR, Shahriari KS, Vosseller K, Reginato MJ. Critical role of O-linked beta-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis. J Biol Chem 2012; 287: 11070-11081.
7. Kamigaito T, Okaneya T, Kawakubo M, Shimojo H, Nishizawa O, Nakayama J. Overexpression of O-GlcNAc by prostate cancer cells is significantly associated with poor prognosis of patients. Prostate Cancer Prostatic Dis 2014; 17: 18-22.
8. Ma ZY, Vocadlo DJ, Vosseller K. Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-kappa B activity in pancreatic cancer cells. J Biol Chem 2013; 288: 15121-15130.
9. Rozanski W, Krzeslak A, Forma E, Brys M, Blewniewski M, Wozniak P et al. Prediction of bladder cancer based on urinary content of MGEA5 and OGT mRNA level. Clin Lab 2012; 58: 579-583.
10. Hart GW, Slawson C, Ramirez-Correa G, Lagerlof O. Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease. Annu Rev Biochem 2011; 80: 825-858.
11. Itkonen HM, Minner S, Guldvik IJ, Sandmann MJ, Tsourlakis MC, Berge V et al. O-GlcNAc transferase integrates metabolic pathways to regulate the stability of c-MYC in human prostate cancer cells. Cancer Res 2013; 73: 5277-5287.
12. Olivier-Van Stichelen S, Drougat L, Dehennaut V, El Yazidi-Belkoura I, Guinez C, Mir AM et al. Serum-stimulated cell cycle entry promotes ncOGT synthesis required for cyclin D expression. Oncogenesis 2012; 1: e36.
13. Yang WH, Kim JE, Nam HW, Ju JW, Kim HS, Kim YS et al. Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability. Nat Cell Biol 2006; 8: 1074-1083. (Pubitemid 44473602)
14. Caldwell SA, Jackson SR, Shahriari KS, Lynch TP, Sethi G, Walker S et al. Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1. Oncogene 2010; 29: 2831-2842.
15. Yang YR, Song M, Lee H, Jeon Y, Choi EJ, Jang HJ et al. O-GlcNAcase is essential for embryonic development and maintenance of genomic stability. Aging Cell 2012; 11: 439-448.
16. Dehennaut V, Lefebvre T, Sellier C, Leroy Y, Gross B, Walker S et al. O-linked N-acetylglucosaminyltransferase inhibition prevents G2/M transition in Xenopus laevis oocytes. J Biol Chem 2007; 282: 12527-12536. (Pubitemid 47100627)
17. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-767.
18. Sayat R, Leber B, Grubac V, Wiltshire L, Persad S. O-GlcNAc-glycosylation of betacatenin regulates its nuclear localization and transcriptional activity. Exp Cell Res 2008; 314: 2774-2787.
19. Smith JJ, Deane NG, Wu F, Merchant NB, Zhang B, Jiang A et al. Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. Gastroenterology 2010; 138: 958-968.
20. Sveen A, Agesen TH, Nesbakken A, Meling GI, Rognum TO, Liestol K et al. ColoGuidePro: a prognostic 7-gene expression signature for stage III colorectal cancer patients. Clin Cancer Res 2012; 18: 6001-6010.
21. Chan TA, Wang Z, Dang LH, Vogelstein B, Kinzler KW. Targeted inactivation of CTNNB1 reveals unexpected effects of beta-catenin mutation. Proc Natl Acad Sci USA 2002; 99: 8265-8270. (Pubitemid 34651041)
22. Ha JR, Hao L, Venkateswaran G, Huang YH, Garcia E, Persad S. beta-Catenin is O-GlcNAc glycosylated at Serine 23: implications for beta-catenin's subcellular localization and transactivator function. Exp Cell Res 2014; 321: 153-166.
23. Mi W, Gu Y, Han C, Liu H, Fan Q, Zhang X et al. O-GlcNAcylation is a novel regulator of lung and colon cancer malignancy. Biochim Biophys Acta 2011; 1812: 514-519.
24. Slawson C, Hart GW. O-GlcNAc signalling: implications for cancer cell biology. Nat Rev Cancer 2011; 11: 678-684.
25. Suh PG, Song M, Kim HS, Parka JM, Kim SH, Kim IH et al. O-GlcNAc transferase is activated by CaMKIV-dependent phosphorylation under potassium chlorideinduced depolarization in NG-108-15 cells. Cell Signal 2008; 20: 94-104. (Pubitemid 350148250)